TANDEM DIABETES CARE INC

TNDM

TANDEM DIABETES CARE INC

TNDM

Insider Sentiment (TTM):

Last Purchase:2025-08-11Last Sale:2026-03-17Shares Purchased (TTM):0Shares Sold (TTM):189

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:74,696,355Shares Outstanding:68,397,000Institutional Ownership Pct.:109.21%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	63	179	91	92	64	54	69	49	48	59	59	80
Short Term Investments	393	391	202	227	251	315	369	424	405	409	409	419
Accounts Receivable Net Current	162	141	165	126	128	127	115	107	98	93	106	100
Inventory Net	135	126	129	137	143	141	150	152	162	154	158	143
Prepaid Expense And Other Assets Current	51	50	31	35	28	27	22	20	21	21	17	16
Assets Current	805	887	618	617	615	663	724	753	733	735	748	758
Property Plant And Equipment Net	85	83	84	78	78	79	78	81	79	78	77	76
Operating Lease Right Of Use Asset	100	96	96	98	98	101	85	87	88	88	88	89
Equity Method Investments	132	56	60	65	68	71	75	-	-	-	0	-
Other Assets Noncurrent	33	31	23	17	17	7	5	36	37	40	40	17
Assets	1,154	1,153	881	875	876	922	968	958	938	941	953	940
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	64	60	47	47	56	60	45	49	48	48	50	46
Accrued Liabilities Current	26	19	21	13	14	14	18	12	13	11	13	14
Employee Related Liabilities Current	53	56	70	64	52	50	64	59	43	42	43	44
Convertible Debt Current	-	-	0	0	0	41	41	41	41	-	0	-
Operating Lease Liability Current	20	20	19	21	20	21	18	18	18	17	17	18
Contract With Customer Liability Current	8	9	10	10	11	11	12	43	44	45	44	32
Other Liabilities Current	81	84	75	97	100	92	49	38	34	30	28	34
Liabilities Current	253	248	243	253	252	288	247	259	241	193	195	187
Convertible Debt Noncurrent	603	602	310	310	309	309	308	308	307	347	285	285
Operating Lease Liability Noncurrent	116	113	115	118	120	123	106	109	111	113	114	116
Contract With Customer Liability Noncurrent	8	8	8	9	10	10	10	11	12	12	13	14
Other Liabilities Noncurrent	44	50	50	52	52	37	32	32	32	32	32	24
Liabilities	1,024	1,021	726	742	742	767	705	720	704	698	639	626
Commitments And Contingencies	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,418	1,400	1,402	1,380	1,360	1,334	1,313	1,282	1,260	1,238	1,264	1,238
Accumulated Other Comprehensive Income Loss Net Of…	6	5	6	5	4	0	-2	4	-1	-1	1	-2
Retained Earnings Accumulated Deficit	-1,294	-1,273	-1,253	-1,252	-1,231	-1,178	-1,048	-1,049	-1,025	-995	-952	-922
Stockholders Equity	130	132	155	133	133	155	263	238	234	243	314	314
Liabilities And Stockholders Equity	1,154	1,153	881	875	876	922	968	958	938	941	953	940
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	70	69	68	68	68	67	66	66	65	65	66	65
Shares Outstanding	70	69	68	68	68	67	66	66	65	65	66	65

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-6.88%	-12.07%	-7.31%	-	-	-	-	-	-	-	-	-
2025	22.97%	20.00%	-12.34%	-13.06%	-16.61%	3.89%	57.61%	67.67%	49.29%	16.58%	3.56%	-16.41%
2024	41.49%	17.18%	19.42%	26.67%	26.75%	0.37%	-10.54%	7.71%	6.60%	-39.60%	-49.81%	-31.29%
2023	-	-	-	-	-	-	7.32%	66.14%	39.44%	26.92%	48.56%	96.72%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.18	3.58	2.55	2.44	2.44	2.30	2.93	2.90	3.05	3.81	3.83	4.05
Quick Ratio	2.44	2.87	1.89	1.76	1.76	1.72	2.24	2.24	2.29	2.91	2.94	3.20
Working Capital	551.63M	639.14M	375.42M	364.40M	363.13M	375.26M	477.44M	493.55M	492.78M	542.22M	552.73M	571.03M
Leverage & Debt
Debt to Equity	7.85	7.71	4.68	5.58	5.57	4.94	2.68	3.03	3.01	2.87	2.04	1.99
Interest Coverage TTM	-5.21	-10.16	-23.68	-25.50	-26.61	-24.16	-13.37	-14.86	-11.62	-12.49	-23.60	-33.51
Debt Ratio	0.89	0.89	0.82	0.85	0.85	0.83	0.73	0.75	0.75	0.74	0.67	0.67
Efficiency & Turnover
Asset Turnover TTM	1.03	0.99	1.10	1.10	1.10	1.06	0.98	0.90	0.84	0.81	0.75	0.78
Days Sales Outstanding TTM	50.91	47.46	50.37	42.25	41.28	40.76	42.73	44.33	45.13	43.69	53.76	50.42
Receivables Turnover TTM	7.17	7.69	7.25	8.64	8.84	8.96	8.54	8.23	8.09	8.35	6.79	7.24
Per Share Metrics
Diluted EPS TTM	-0.92	-1.38	-3.04	-3.01	-3.06	-2.77	-1.47	-1.93	-2.10	-2.17	-3.43	-3.20
Free Cash Flow Per Share TTM	-0.39	-0.05	-0.44	-0.37	-0.12	-0.06	0.08	-0.23	-0.65	-0.67	-0.90	-0.71
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	56.01%	54.93%	53.81%	53.23%	52.55%	52.22%	52.07%	49.79%	49.06%	49.28%	49.17%	50.55%
Operating Profit Margin TTM	-4.40%	-8.16%	-18.45%	-19.48%	-19.90%	-18.14%	-10.54%	-15.64%	-17.47%	-19.10%	-31.19%	-27.99%
Net Profit Margin TTM	-6.08%	-9.20%	-20.17%	-20.20%	-20.51%	-18.71%	-10.21%	-14.84%	-17.15%	-18.37%	-29.77%	-27.02%
Growth Metrics
Net Revenue Growth (1Y)	3.96%	4.54%	7.93%	17.87%	25.84%	27.65%	25.74%	10.75%	0.72%	-3.11%	-6.68%	-2.44%
Net Income Growth (1Y)	-69.18%	-48.58%	113.18%	60.41%	50.52%	29.98%	-56.86%	-39.18%	-39.19%	-30.58%	135.33%	206.86%
EPS Growth (1Y)	-70.06%	-50.08%	107.37%	55.39%	45.91%	27.87%	-57.18%	-39.57%	-39.35%	-31.40%	132.35%	202.71%
Valuation Metrics
P/E TTM	-16.45	-13.87	-7.22	-4.04	-6.08	-6.92	-24.55	-21.92	-19.19	-16.35	-8.63	-6.49
P/B TTM	7.99	9.90	9.53	6.18	9.38	8.19	8.96	11.69	11.20	9.52	6.13	4.31
P/S TTM	1.00	1.28	1.46	0.82	1.25	1.29	2.51	3.25	3.29	3.00	2.57	1.75
Market Cap	1.04B	1.31B	1.48B	821.30M	1.25B	1.27B	2.36B	2.78B	2.62B	2.31B	1.92B	1.35B
Enterprise Value	1.58B	1.73B	1.70B	1.04B	1.49B	1.57B	2.64B	3.08B	2.92B	2.60B	2.15B	1.56B
Calculated Values
Free Cash Flow TTM	-26.62M	-3.64M	-29.67M	-25.13M	-7.76M	-3.80M	4.99M	-15.07M	-41.95M	-43.91M	-58.61M	-46.01M
Net Debt	539.76M	422.44M	219.40M	217.64M	245.03M	295.87M	279.70M	299.40M	300.24M	288.52M	226.17M	204.97M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-17Sale

Owner: Novara, Mark David

Title: EVP & CHIEF COMMERCIAL OFFICER

Shares: 187

Price/Share: $23.05

Value: $4,310.35

Shares Owned: 37,656

Relationship: Officer

Ownership: Direct

2026-03-05Sale

Owner: Novara, Mark David

Title: EVP & CHIEF COMMERCIAL OFFICER

Shares: 2

Price/Share: $22.81

Value: $45.62

Shares Owned: 35,969

Relationship: Officer

Ownership: Direct

2025-08-11Purchase

Owner: Sheridan, John F

Title: PRESIDENT & CEO

Shares: 10,000

Price/Share: $10.23

Value: $102,300.00

Shares Owned: 106,327

Relationship: Director,Officer

Ownership: Direct

2025-08-08Purchase

Owner: Vosseller, Leigh

Title: EVP & CHIEF FINANCIAL OFFICER

Shares: 13,720

Price/Share: $10.89

Value: $149,410.80

Shares Owned: 25,580

Relationship: Officer

Ownership: Indirect

2025-03-07Purchase

Owner: Kyrillos, Jean-Claude

Title: EVP & Chief Operating Officer

Shares: 10,538

Price/Share: $18.12

Value: $190,948.56

Shares Owned: 10,538

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-17	Novara, Mark David	Officer	EVP & CHIEF COMMERCIAL OFFICER	Direct	Sale	187	23.05	$4,310.35	37,656	4
2026-03-05	Novara, Mark David	Officer	EVP & CHIEF COMMERCIAL OFFICER	Direct	Sale	2	22.81	$45.62	35,969	4
2025-08-11	Sheridan, John F	Director,Officer	PRESIDENT & CEO	Direct	Purchase	10,000	10.23	$102,300.00	106,327	4
2025-08-08	Vosseller, Leigh	Officer	EVP & CHIEF FINANCIAL OFFICER	Indirect	Purchase	13,720	10.89	$149,410.80	25,580	4
2025-03-07	Kyrillos, Jean-Claude	Officer	EVP & Chief Operating Officer	Direct	Purchase	10,538	18.12	$190,948.56	10,538	4
2024-11-21	Blickenstaff, Kim D	Director	-	Indirect	Sale	30,000	31.38	$941,400.00	165,190	4
2024-11-15	Novara, Mark David	Officer	EVP & CHIEF COMMERCIAL OFFICER	Direct	Purchase	532	23.24	$12,363.68	532	4
2024-05-30	Allen, Dick	Director	-	Indirect	Sale	5,000	51.68	$258,400.00	0	4
2023-11-27	Allen, Dick	Director	-	Direct	Purchase	5,000	18.96	$94,800.00	19,962	4
2023-11-08	Hansen, Shannon Marie	Officer	Chief Legal Officer	Indirect	Purchase	1,935	15.44	$29,876.40	1,935	4
2023-11-08	Vosseller, Leigh	Officer	EVP & CHIEF FINANCIAL OFFICER	Indirect	Purchase	6,200	15.39	$95,418.00	11,860	4
2023-09-15	Mcgroddy-Goetz, Kathleen	Director	-	Direct	Purchase	1,000	21.45	$21,450.00	9,032	4
2023-05-18	Allen, Dick	Director	-	Direct	Purchase	10,000	29.47	$294,700.00	12,205	4
2023-05-17	Howell, Peyton R	Director	-	Direct	Purchase	3,000	30.16	$90,480.00	8,550	4
2023-05-12	Vosseller, Leigh	Officer	EVP & CHIEF FINANCIAL OFFICER	Indirect	Purchase	3,015	32.77	$98,801.55	5,660	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

109.21%

Inst. Shares: 74,696,355

Shares Outstanding: 68,397,000

2025-12-31

105.30%

Inst. Shares: 70,851,594

Shares Outstanding: 67,285,000

2025-09-30

103.89%

Inst. Shares: 70,282,333

Shares Outstanding: 67,652,000

2025-06-30

111.84%

Inst. Shares: 74,985,400

Shares Outstanding: 67,050,000

2025-03-31

101.58%

Inst. Shares: 67,456,090

Shares Outstanding: 66,404,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	74,696,355	68,397,000	109.21%
2025-12-31	70,851,594	67,285,000	105.30%
2025-09-30	70,282,333	67,652,000	103.89%
2025-06-30	74,985,400	67,050,000	111.84%
2025-03-31	67,456,090	66,404,000	101.58%
2024-12-31	67,996,550	65,451,000	103.89%
2024-09-30	69,857,164	65,538,000	106.59%
2024-06-30	70,327,777	64,994,000	108.21%
2024-03-31	70,585,537	65,326,000	108.05%
2023-12-31	67,924,912	64,969,000	104.55%
2023-09-30	67,826,114	65,117,000	104.16%
2023-06-30	64,626,882	64,830,000	99.69%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

TANDEM DIABETES CARE INC (TNDM) — SEC Financial Statements & Analysis

TANDEM DIABETES CARE INC (TNDM) is a surgical & medical instruments & apparatus company, incorporated in DE. TANDEM DIABETES CARE INC trades on Nasdaq as: TNDM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), TANDEM DIABETES CARE INC reported a 3.96% year-over-year revenue growth, a Gross Profit Margin of 56.01% (TTM), a Debt-to-Equity ratio of 7.85x, a Price-to-Sales (P/S) ratio of 1.00x (TTM), a Price-to-Book (P/B) ratio of 7.99x (TTM), at a market cap of $1.04B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 3.96%
Gross Profit Margin TTM: 56.01%
Debt To Equity: 7.85x
P/S TTM: 1.00x
P/B TTM: 7.99x
Market Cap: $1.04B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TANDEM DIABETES CARE INC in?

TANDEM DIABETES CARE INC (TNDM) operates in the Surgical & Medical Instruments & Apparatus industry.

What is TNDM's market cap?

TANDEM DIABETES CARE INC (TNDM) has a market capitalization of $1.04B as of 2026-06-30.

What exchange does TNDM trade on?

TANDEM DIABETES CARE INC (TNDM) trades on the Nasdaq.

Where is TANDEM DIABETES CARE INC incorporated?

TANDEM DIABETES CARE INC is incorporated in DE.